Literature DB >> 3041901

When and how should we measure plasma ammonia?

A Green1.   

Abstract

Hyperammonaemia is associated with a high morbidity and mortality. It is important to diagnose as it is often treatable and perhaps, most importantly, may be genetically determined. Measurement of plasma ammonia is rarely necessary in adult medicine. In paediatrics, and particularly in the neonatal period, it is an important investigation in the diagnosis and often in the subsequent management of several inherited metabolic disorders. Patients with these disorders, particularly neonates, will deteriorate over a period of hours and investigation cannot wait. In these situations a plasma ammonia together with other investigations for metabolic disorders must be available urgently and are sometimes necessary out of normal laboratory hours. Interpretation must take into account the age and maturity of the child as well as the clinical state and results of other investigations. If treatment is initiated, frequent monitoring of plasma ammonia may be required. Plasma ammonia can be reliably and conveniently measured using a specific ion-selective electrode system or an automated enzyme method. Screening using a microdiffusion method is not a satisfactory alternative to a quantitative assay. Plasma ammonia is no longer solely the province of the specialised paediatric laboratory, but should be part of the repertoire of every laboratory supporting neonatal or paediatric units. The threshold for accepting requests should be lower than at present if we are to prevent misdiagnoses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3041901     DOI: 10.1177/000456328802500301

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  3 in total

1.  ACP Broadsheet 120: January 1989. Guide to diagnosis of inborn errors of metabolism in district general hospitals.

Authors:  A Green
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

2.  A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.

Authors:  Rodrigo C Surjan; Elizabeth S Dos Santos; Tiago Basseres; Fabio F Makdissi; Marcel A Machado
Journal:  Am J Case Rep       Date:  2017-03-08

3.  Astrocytes profiling in acute hepatic encephalopathy: Possible enrolling of glial fibrillary acidic protein, tumor necrosis factor-alpha, inwardly rectifying potassium channel (Kir 4.1) and aquaporin-4 in rat cerebral cortex.

Authors:  Dalia Mahmoud Abdelmonem Elsherbini; Fatma M Ghoneim; Eman Mohammed El-Mancy; Hasnaa Ali Ebrahim; Mohamed El-Sherbiny; Mohamed El-Shafey; Rasha Hamed Al-Serwi; Nehal M Elsherbiny
Journal:  Front Cell Neurosci       Date:  2022-08-17       Impact factor: 6.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.